Edonerpic
Small moleculeexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2008 (NCT00663936)
Timeline
Indications
Mechanism of action
DPYSL2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 1-(3-(2-(1-benzothiophen-5-yl) ethoxy) propyl)-3-azetidinol maleate
- t-817ma
- t-817ma
- t-817ma
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04191486 | Phase 2 | Dec 31, 2019 | Free University of Amsterdam, Toyama |
| NCT02693197 | Phase 1 | Feb 1, 2016 | Celerion, Orlando Clinical Research Center, Toyama, University of Miami |
| NCT02079909 | Phase 2 | Mar 1, 2014 | National Institute on Aging (NIA), Toyama |
| NCT00663936 | Phase 2 | Apr 1, 2008 | Toyama |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Toyama | For profit | 4 | 4 | 2 | 2008 |
| Celerion | For profit | 1 | 0 | 1 | 2016 |
| Free University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2019 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2014 |
| Orlando Clinical Research Center | For profit | 1 | 0 | 1 | 2016 |
| University of Miami | Academic/Hospital | 1 | 0 | 1 | 2016 |
6 organizations
Page 1 / 1